Skip to main content

Publisher: Wiley-Blackwell

Volume 16, Supplement 1, February 2006

Favourites:
ADD

Stage- and CA125–related survival in patients with epithelial ovarian cancer treated at a cancer center
pp. 18-24(7)
Authors: BOARD; BRUIJNS; PRONK; RYDER; WILKINSON; WELCH; SHANKS; CONNOLLY; SLADE; REYNOLDS; KITCHENER; JAYSON

Favourites:
ADD
Favourites:
ADD
Favourites:
ADD
Favourites:
ADD

A retrospective analysis of neoadjuvant platinum-based chemotherapy versus up-front surgery in advanced ovarian cancer
pp. 47-53(7)
Authors: STEED; OZA; MURPHY; LAFRAMBOISE; LOCKWOOD; DE PETRILLO; STURGEON; ROSEN

Favourites:
ADD

Efficacy of screening women at high risk of hereditary ovarian cancer: results of an 11-year cohort study
pp. 54-59(6)
Authors: GAARENSTROOM; van derHIEL; TOLLENAAR; VINK; JANSEN; vanASPEREN; KENTER

Favourites:
ADD

Topotecan and liposomal doxorubicin in recurrent ovarian cancer: is sequence important?
pp. 68-73(6)
Authors: DUPONT; AGHAJANIAN; ANDREA; LOVEGREN; CHUAI; VENKATRAMAN; HENSLEY; ANDERSON; SPRIGGS; SABBATINI

Favourites:
ADD

Epidoxorubicin versus no treatment as consolidation therapy in advanced ovarian cancer: results from a phase II study
pp. 74-78(5)
Authors: BOLIS; DANESE; TATEO; RABAIOTTI; D’AGOSTINO; MERISIO; SCARFONE; POLVERINO; PARAZZINI

Favourites:
ADD

A phase II study of pegylated liposomal doxorubicin oxaliplatin and cyclophosphamide as second-line treatment in relapsed ovarian carcinoma
pp. 79-85(7)
Authors: VALERIO; TAGLIAFERRI; RASPAGLIESI; FULFARO; BADALAMENTI; ARCARA; CICERO; RUSSO; VENUTA; GUARNERI; GEBBIA

Favourites:
ADD

Screening for familial ovarian cancer—management and outcome of women with moderate to high risk of developing ovarian cancer
pp. 86-91(6)
Authors: RIECK; LIM; ROGERS; FRANCE; GRAY; AMSO; EVANS; HOWELLS; FIANDER

Favourites:
ADD

Whole-body positron emission tomography and tumor marker CA125 for detection of recurrence in epithelial ovarian cancer
pp. 99-107(9)
Authors: MURAKAMI; MIYAMOTO; IIDA; TSUKADA; WATANABE; SHIDA; MAEDA; NASU; YASUDA; YASUDA; IDE

Favourites:
ADD

Image-guided biopsy in women with breast cancer presenting with peritoneal carcinomatosis
pp. 108-110(3)
Authors: HEWITT; HALL; WILKINSON; PERREN; LANE; SPENCER

Favourites:
ADD
Favourites:
ADD

Primary gynecological neoplasms and clinical outcomes in patients diagnosed with breast carcinoma
pp. 118-122(5)
Authors: ESCOBAR; PATRICK; RYBICKI; AL-HUSAINI; MICHENER; CROWE

Favourites:
ADD
Favourites:
ADD

Primary psammocarcinoma of the peritoneum
pp. 129-131(3)
Authors: BİLGİN; ÖZUYSAL; CANKILIÇ

Favourites:
ADD

Metastatic tumors to the ovaries: a study of 170 cases in northern Thailand
pp. 132-138(7)
Authors: KHUNAMORNPONG; SUPRASERT; NA CHIANGMAI; SIRIAUNKGUL

Favourites:
ADD

Plasma proteomic pattern as biomarkers for ovarian cancer
pp. 139-146(8)
Authors: LIN; LIN; LAI; CHIOU; CHANG; YU; CHU

Favourites:
ADD

Predicting the clinical behavior of ovarian cancer from gene expression profiles
pp. 147-151(5)
Authors: DE SMET; POCHET; ENGELEN; VAN GORP; VAN HUMMELEN; MARCHAL; AMANT; TIMMERMAN; DE MOOR; VERGOTE

Favourites:
ADD

Molecular prognostic markers in ovarian cancer: toward patient-tailored therapy
pp. 152-165(14)
Authors: CRIJNS; DUIKER; deJONG; WILLEMSE; van derZEE; deVRIES

Favourites:
ADD

BRCA1 expression in a large series of sporadic ovarian carcinomas: a Gynecologic Oncology Group study
pp. 166-171(6)
Authors: THRALL; GALLION; KRYSCIO; KAPALI; ARMSTRONG; DELOIA

Favourites:
ADD

BRCA1 germline mutations in Chinese patients with hereditary breast and ovarian cancer
pp. 172-178(7)
Authors: LI; ZHANG; CAI; XU; ZHANG; PAN; WU; WANG

Favourites:
ADD

Fas gene promoter –670 polymorphism in gynecological cancer
pp. 179-182(4)
Authors: UEDA; TERAI; KANDA; KANEMURA; TAKEHARA; YAMAGUCHI; NISHIYAMA; YASUDA; UEKI

Favourites:
ADD

Prognostic significance of vascular endothelial growth factor expression in ovarian cancer patients: a long-term follow-up
pp. 183-189(7)
Authors: RUDLOWSKI; PICKART; FUHLJAHN; FRIEPOERTNER; SCHLEHE; BIESTERFELD; SCHROEDER

Favourites:
ADD

Methylation of death-associated protein kinase in ovarian carcinomas
pp. 195-199(5)
Authors: COLLINS; DICIOCCIO; KEITZ; LELE; ODUNSI

Favourites:
ADD

Ras antagonist inhibits growth and chemosensitizes human epithelial ovarian cancer cells
pp. 200-206(7)
Authors: BEINER; NIV; HAKLAI; ELAD-SFADIA; KLOOG; BEN-BARUCH

Favourites:
ADD

Atypical reactive ovarian surface epithelium, a pitfall in pathologic assessment
pp. 207-210(4)
Authors: AYDIN; ÇELIK; HASÇALIK; EDALI

Favourites:
ADD

Active and passive smoking and risk of ovarian cancer
pp. 211-218(8)
Authors: BAKER; ODUNUGA; RODABAUGH; REID; MENEZES; MOYSICH

Favourites:
ADD

Complementary and alternative medicine use in patients with gynecological cancers in Europe
pp. 219-224(6)
Authors: MOLASSIOTIS; BROWALL; MILOVICS; PANTELI; PATIRAKI; FERNANDEZ-ORTEGA

Favourites:
ADD
Favourites:
ADD
Favourites:
ADD
Favourites:
ADD

Microsatellite instability in mitochondrial genome of common female cancers
pp. 259-266(8)
Authors: WANG; LIU; TSANG; CHIU; CHEUNG; KHOO; NAGLEY; NGAN

Favourites:
ADD
Favourites:
ADD
Favourites:
ADD

Uterine papillary serous carcinoma: evaluation of multimodality treatment with abdominopelvic radiotherapy and chemotherapy
pp. 278-285(8)
Authors: STEED; MANCHUL; ROSEN; FYLES; LOCKWOOD; LAFRAMBOISE; MURPHY; MILOSEVIC; CHAPMAN; OZA

Favourites:
ADD

Immunohistochemical characterization of endocervical papillary serous carcinoma
pp. 286-292(7)
Authors: NOFECH-MOZES; RASTY; ISMIIL; COVENS; KHALIFA

Favourites:
ADD

Paraparesis: a rare primary presentation of epithelial ovarian cancer
pp. 293-294(2)
Authors: WUNTKAL; MAHESHWARI; GUPTA; TONGAONKAR

Favourites:
ADD
Favourites:
ADD

Disseminated peritoneal tuberculosis mimicking advanced-stage endodermal sinus tumor: a case report
pp. 303-307(5)
Authors: DURSUN; ERSOZ; GULTEKIN; AKSAN; YÜCE; AYHAN

Favourites:
ADD

Extranodal Rosai–Dorfman disease as a pelvic mass
pp. 312-315(4)
Authors: LEIVA; BOFILL; SEVIN; GEIGER

Favourites:
ADD

Elevated CA125 level associated with Meigs’ syndrome: case report and review of the literature
pp. 315-318(4)
Authors: MORÁN-MENDOZA; ALVARADO-LUNA; CALDERILLO-RUIZ; SERRANO-OLVERA; LÓPEZ-GRANIEL; GALLARDO-RINCÓN

Favourites:
ADD
Favourites:
ADD
Favourites:
ADD

Proton magnetic resonance spectroscopy findings of a sacrococcygeal schwannoma
pp. 344-348(5)
Authors: HASCALIK; CELIK; ERDEM; ARA; KIRIMLIOGLU

Favourites:
ADD

A case report of primary osteosarcoma of the ovary
pp. 349-352(4)
Authors: VYAS; RAMMAH; ASHEBU; SHARAAN; EL-SAYED; JARSLOV; EL-KHODARY

Favourites:
ADD

Malignant fibrous histiocytoma of the ovary: a case report
pp. 352-356(5)
Authors: DILEK; DILEK; PATA; TATAROGLU; TOK

Favourites:
ADD
Favourites:
ADD

Malignant epithelioid ovarian schwannoma: a case report
pp. 360-362(3)
Authors: LÁSZLÓ; IVASKEVICS; SÁPI

Favourites:
ADD
Favourites:
ADD

An unusual case of primary fallopian tube carcinoma in pregnancy
pp. 365-368(4)
Authors: BATRA; SINGH; WYNN

Favourites:
ADD
Favourites:
ADD

An ovarian dysgerminoma in Down syndrome. Hypothesis about the association
pp. 375-379(5)
Authors: SATGÉ; HONORÉ; SASCO; VEKEMANS; CHOMPRET; RÉTHORÉ

Favourites:
ADD

Mucoepidermoid variant of adenosquamous carcinoma arising in ovarian dermoid cyst: a case report and review of the literature
pp. 379-384(6)
Authors: KARATEKE; GURBUZ; KIR; HALILOGLU; KABACA; DEVRANOGLU; YAKUT

Favourites:
ADD

The growing teratoma syndrome: a case report and a review of the literature
pp. 384-390(7)
Authors: TANGJITGAMOL; MANUSIRIVITHAYA; LEELAHAKORN; THAWARAMARA; SUEKWATANA; SHEANAKUL

Favourites:
ADD

Fatal pulmonary fibrosis induced by paclitaxel: a case report and review of the literature
pp. 391-393(3)
Authors: OSTOROS; PRETZ; FILLINGER; SOLTESZ; DOME

Favourites:
ADD

Recurrent ovarian dysgerminoma after laparoscopy
pp. 397-399(3)
Authors: PRADO; YAZIGI; GARRIDO; GONZALEZ; TORRES; ODDO

Favourites:
ADD

Mesovarian hemangioma presenting as massive ascites, pelvic mass, and elevated CA125
pp. 412-414(3)
Authors: ABU; BROWN; IRELAND; SIZELAND

Favourites:
ADD

Skin metastasis in ovarian carcinoma
pp. 414-418(5)
Authors: YILMAZ; BESE; DEMIRKIRAN; ILVAN; SANIOGLU; ARVAS; KOSEBAY

Favourites:
ADD
Favourites:
ADD

Primary “breast-like” cancer of the vulva: a case report and critical review of the literature
pp. 423-428(6)
Authors: FRACCHIOLI; PUOPOLO; RIGAULT DE LA LONGRAIS; SCOZZAFAVA; BOGLIATTO; ARISIO; MICHELETTI; KATSAROS

Favourites:
ADD

Metastatic extragenital neoplasms to the uterus: a clinicopathologic study of four cases
pp. 433-438(6)
Authors: GIORDANO; GNETTI; RICCI; MERISIO; MELPIGNANO

Favourites:
ADD
Favourites:
ADD

CYP17 genetic polymorphism in patients with endometrial hyperplasia and cancer
pp. 448-451(4)
Authors: ABAN; ARSLAN; TOK; TEKES; BUDAK; ALTINTAS

Favourites:
ADD

Significance of p27 as a predicting marker for medroxyprogesterone acetate therapy against endometrial endometrioid adenocarcinoma
pp. 452-457(6)
Authors: WATANABE; WATANABE; JOBO; KAMATA; KAWAGUCHI; IMAI; OKAYASU; KURAMOTO

Favourites:
ADD

Venous thromboembolism syndrome in gynecological cancer
pp. 458-471(14)
Authors: WANG; FU; FREEDMAN; KAVANAGH

Favourites:
ADD

The loneliness level of patients with gynecological cancer
pp. 472-477(6)
Authors: SEVIL; ERTEM; KAVLAK; ÇOBAN

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more